Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration.

IF 1.4 4区医学 Q3 OPHTHALMOLOGY

European Journal of Ophthalmology Pub Date : 2024-09-27 DOI:10.1177/11206721241286708

Sang Hyeok Lee, Mee Yon Lee

引用次数: 0

Abstract

Purpose: To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date.

Case description: A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole.

Outcome: Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated.

Conclusion: Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.

查看原文本刊更多论文

新生血管性年龄相关性黄斑变性静脉注射肉毒杆菌后的全厚黄斑孔。

目的：描述一例新血管性年龄相关性黄斑变性患者玻璃体内注射博路单抗后出现全厚黄斑孔的病例，该病例迄今尚未见报道：一名 65 岁的男性患者因右眼新生血管性黄斑变性接受了布鲁珠单抗的玻璃体内注射治疗。他按照原方案接受了多次玻璃体内抗血管内皮生长因子注射，结果出现了全厚黄斑孔：手术治疗：右眼玻璃体旁切除术。结论：尽管玻璃体内注射肉毒杆菌后出现全厚黄斑孔是一种不常见的并发症，但仍需谨慎对待。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Ophthalmology 医学-眼科学

CiteScore

3.60

自引率

0.00%

发文量

372

审稿时长

3-8 weeks

期刊介绍： The European Journal of Ophthalmology was founded in 1991 and is issued in print bi-monthly. It publishes only peer-reviewed original research reporting clinical observations and laboratory investigations with clinical relevance focusing on new diagnostic and surgical techniques, instrument and therapy updates, results of clinical trials and research findings.